ESR1 and breast carcinoma: ESR1 chromosomal translocation events also occur in endocrine-resistant, metastatic breast cancer patients resulting in fusion proteins possessing the N terminus and DNA-binding domain (DBD) of ERα, but containing partners from various genes that replace the LBD [11, 20].